Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects
Status:
Unknown status
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this open-label, randomized, two-period, two-treatment (single doses of 10 mg
SHR0302 fasted or fed), crossover study was to evaluate the effect of a high-fat meal on the
pharmacokinetics of SHR0302 and mass balance study in 14 healthy subjects.